Irina Randrianjatovo-Gbalou

Irina Randrianjatovo-Gbalou currently serves as the Chief Executive Officer at Ispiron Biotechnologies, a position held since September 2024. Prior to this role, Irina was the Head of the Quantoom Research Center at Quantoom Biosciences from January 2022 to September 2024 and served as CEO of Synhelix from March 2019 to February 2022. Irina's earlier experience includes a postdoctoral researcher position at Institut Pasteur, focusing on DNA/RNA polymerases engineering and synthetic biology, and a Ph.D. candidate role at Laboratoire des Biotechnologies Agroalimentaire et Environnementale, concentrating on bacterial biofilms and exopolymeric substances. Academic qualifications include a Ph.D. in Enzyme and Bacterial Engineering from Université Paul Sabatier Toulouse III, an Engineer's degree in Biochemical Engineering from INSA Toulouse, and further education in Entrepreneurship and Business Innovation from HEC Paris.